Mrs Paula Rich, OTR | |
1407 N Whisenant Dr, Duncan, OK 73533-1650 | |
(580) 251-8460 | |
Not Available |
Full Name | Mrs Paula Rich |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1407 N Whisenant Dr, Duncan, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225247901 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT461 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Paula Rich, OTR 2302 S Heffington Rd, Marlow, OK 73055-5232 Ph: (580) 658-9176 | Mrs Paula Rich, OTR 1407 N Whisenant Dr, Duncan, OK 73533-1650 Ph: (580) 251-8460 |
News Archive
MergerTech Advisors is excited to announce the launch of 'MergerTech Capital', a new $50 million venture capital fund. The fund will focus on the investment and development of healthcare IT product and services firms, building on the sectors' substantial potential for extraordinary growth and creativity.
A recent theory suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was doing the rounds in California as early as November 2019, infecting thousands undetected and leading to herd immunity, was debunked by experts from the scientific community. Antibody testing by a group of Stanford Medicine researchers was linked to the theory.
Nerve cells that produce dopamine for the purpose of transmitting signals to other cells affect numerous crucial brain functions.
For decades, scientists have thought the bacteria that cause the bubonic plague hijack host cells at the site of a fleabite and are then taken to the lymph nodes, where the bacteria multiply and trigger severe disease. But UNC School of Medicine researchers discovered that this accepted theory is off base. The bacteria do not use host cells; they traffic to lymph nodes on their own and not in great numbers.
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
› Verified 1 days ago
Mrs. Beth A Wood, OTR/L CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1407 N Whisenant Dr, Duncan Regional Hospital, Duncan, OK 73533 Phone: 580-251-8460 Fax: 580-251-8979 | |
Mrs. Bethany Paige Dempsey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1314 N 12th St, Duncan, OK 73533 Phone: 580-467-5825 Fax: 580-251-9895 | |
Makenzie Rae Lovett, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2150 W Elk Ave, Duncan, OK 73533 Phone: 580-251-8463 | |
Leslie Elizabeth Mcintyre, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1407 N Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8460 | |
Linda Alvis, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Spruce Ave, Duncan, OK 73533 Phone: 623-850-2690 | |
Jessie Harder, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2150 W Elk Ave, Duncan, OK 73533 Phone: 580-251-8460 |